Cellebrite DI Ltd. (CLBT)
$11.62
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Key data on CLBT
Market cap
$2.92B
EPS
0.31
P/E ratio
--
Price to sales
6.25
Dividend yield
--
Beta
1.146054
Price on CLBT
Previous close
$11.82
Today's open
$11.82
Day's range
$11.50 - $11.82
52 week range
$9.58 - $19.98
Profile about CLBT
show more
CEO
Shiven Ramji
Employees
1167
Headquarters
Petah Tikva,
Exchange
Nasdaq Global Select
Shares outstanding
251341060
Issue type
Common Stock
Popular stocks like CLBT
CLBT industries and sectors
Technology
Software & IT Services
News on CLBT
Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 18, 2026
Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals
Purpose-built platform connects customers worldwide with peers and Cellebrite experts into an always-on community TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
PRNewsWire • Sep 17, 2026
CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $CLBT--CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law.
Business Wire • Sep 17, 2026
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (CLBT) to a Securities Law Investigation
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 16, 2026
Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript
Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript
Seeking Alpha • Sep 14, 2026
Cellebrite Initiates Plans to Redomicile in the United States
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
PRNewsWire • Sep 14, 2026
Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research
Strategic move strengthens Cellebrite's flagship access, extraction and decoding technology as Cellebrite Labs joins Wade's Innovation Hub TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
PRNewsWire • Sep 14, 2026
Kaplan Fox Announces an Investigation into Cellebrite DI Ltd. (CLBT) on Behalf of Investors
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 14, 2026
Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation
New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 10, 2026
Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations
New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 8, 2026
¹ Disclosures
Invest in Cellebrite DI Ltd.
Open an M1 investment account to buy and sell Cellebrite DI Ltd. commission-free¹. Build wealth for the long term using automated trading and transfers.